MiR-34b is associated with clinical outcome in triple-negative
breast cancer patients.

J 2012

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.

SVOBODA, Marek; Jiří ŠÁNA; Martina RÉDOVÁ; Jiří NAVRÁTIL; Markéta PALÁCOVÁ et. al.

Základní údaje

Originální název

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.

Autoři

SVOBODA, Marek; Jiří ŠÁNA; Martina RÉDOVÁ; Jiří NAVRÁTIL; Markéta PALÁCOVÁ; Pavel FABIAN; Ondřej SLABÝ a Rostislav VYZULA

Vydání

Diagnostic Pathology, 2012, 1746-1596

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 1.850

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1186/1746-1596-7-31

UT WoS

000303885300001

Klíčová slova anglicky

triple-negative breast cancer; miR-34a; miR-34b; miR-34c; prognosis

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 15. 10. 2015 13:07, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Breast cancer is the most common malignancy with the highest incidence rates among women worldwide. Triple-negative breast cancer (TNBC) represents the major phenotype of basal-like molecular subtype of breast cancer, characterized by higher incidence in young women and a very poor prognosis. MicroRNAs (miRNAs) are small non-coding RNAs playing significant role in the pathogenesis of many cancers including breast cancer. Therefore, miRNAs are also potential prognostic and/or predictive biomarkers in triple-negative breast cancer patients.

Návaznosti

NS10357, projekt VaV

Název: Epidemiologické, genetické a klinicko-patologické aspekty ?triple-negativního? (ER-?, PR, c-ErbB2 negativního) karcinomu prsu v populaci českých žen.

Citovat

SVOBODA, Marek; Jiří ŠÁNA; Martina RÉDOVÁ; Jiří NAVRÁTIL; Markéta PALÁCOVÁ; Pavel FABIAN; Ondřej SLABÝ a Rostislav VYZULA. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Diagnostic Pathology. 2012, roč. 7, March, s. 31-35. ISSN 1746-1596. Dostupné z: https://dx.doi.org/10.1186/1746-1596-7-31.

@article{984200,
   author = {Svoboda, Marek and Šána, Jiří and Rédová, Martina and Navrátil, Jiří and Palácová, Markéta and Fabian, Pavel and Slabý, Ondřej and Vyzula, Rostislav},
   article_number = {March},
   doi = {http://dx.doi.org/10.1186/1746-1596-7-31},
   keywords = {triple-negative breast cancer; miR-34a; miR-34b; miR-34c; prognosis},
   language = {eng},
   issn = {1746-1596},
   journal = {Diagnostic Pathology},
   title = {MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.},
   url = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349474/?tool=pubmed},
   volume = {7},
   year = {2012}
}

TY  - JOUR
ID  - 984200
AU  - Svoboda, Marek - Šána, Jiří - Rédová, Martina - Navrátil, Jiří - Palácová, Markéta - Fabian, Pavel - Slabý, Ondřej - Vyzula, Rostislav
PY  - 2012
TI  - MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.
JF  - Diagnostic Pathology
VL  - 7
IS  - March
SP  - 31-35
EP  - 31-35
SN  - 17461596
KW  - triple-negative breast cancer
KW  - miR-34a
KW  - miR-34b
KW  - miR-34c
KW  - prognosis
UR  - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349474/?tool=pubmed
N2  - Breast cancer is the most common malignancy with the highest incidence rates among women worldwide. Triple-negative breast cancer (TNBC) represents the major phenotype of basal-like molecular subtype of breast cancer, characterized by higher incidence in young women and a very poor prognosis. MicroRNAs (miRNAs) are small non-coding RNAs playing significant role in the pathogenesis of many cancers including breast cancer. Therefore, miRNAs are also potential prognostic and/or predictive biomarkers in triple-negative breast cancer patients.
ER  -

SVOBODA, Marek; Jiří ŠÁNA; Martina RÉDOVÁ; Jiří NAVRÁTIL; Markéta PALÁCOVÁ; Pavel FABIAN; Ondřej SLABÝ a Rostislav VYZULA. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. \textit{Diagnostic Pathology}. 2012, roč.~7, March, s.~31-35. ISSN~1746-1596. Dostupné z: https://dx.doi.org/10.1186/1746-1596-7-31.

Přehled o publikaci